Clinical Trial Update: Double-blind Comparative Study of SYR-472 [Phase 3]

View source ↗

Summary

Phase 3 double-blind comparative study of SYR-472 in diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• SYR-472

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED